Partners with MediScan Systems to Increase Availability of Maternal and Neonatal Diagnostics CHENNAI, India–PerkinElmer, Inc. (NYSE: PKI), a global leader focused on improving the health and safety of people and their environment, today announced that it has expanded its fetal, maternal and neonatal health screening capability in India, with the inauguration of the PerkinElmer Health […]
Control Kits Will Strengthen Affymetrix’ Diagnostic Product Portfolio AUSTIN, Texas–Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix (Nasdaq:AFFX). The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that […]
Investigational AmpliChip p53 Test Designed to Screen for Genetic Mutation Tied to Therapeutic Resistance in Cancer Patients PLEASANTON, Calif. — Roche Molecular Systems, Inc. (SIX: RO, ROG; OTCQX: RHHBY) announced today a research collaboration with Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.) providing Merck access to Roche’s developmental microarray-based AmpliChip […]
Continued Roll-out of Innovative Molecular Laboratory Developed Tests from Sequenom Center for Molecular Medicine SAN DIEGO — Sequenom, Inc. (Nasdaq:SQNM – News) today announced the launch of the SensiGeneâ„¢ Fetal(XY) (Fetal Sex Determination) test by Sequenom’s CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM). This is the company’s second laboratory developed […]
Runcorn, Cheshire, United Kingdom — Thermo Fisher Scientific Inc., announced that The Robert Jones and Agnes Hunt Orthopaedic and District Hospital (RJAH), the UK’s leading orthopedic hospital, has chosen the Thermo Scientific Excelsior ES tissue processor (NYSE: TMO). Thermo Fisher Scientific Inc., the world leader in serving science, today announced that The Robert Jones and […]
VENLO, The Netherlands, and ALAMEDA, California — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and Celera Corporation (NASDAQ:CRA) today announced an agreement under which QIAGEN will distribute a Celera molecular multiplex assay. The assay is the next generation version of QIAGEN’s ResPlex II assay for detection of respiratory pathogens. Multiplex assays allow testing for […]
Cancer Diagnostics and Chromatography Products RUNCORN, Cheshire — Thermo Fisher Scientific Inc., the world leader in serving science, today announced the official opening of its new cutting-edge facility in Runcorn, Cheshire. The new facility, located at Tudor Road, Manor Park, is a significant investment for Thermo Fisher Scientific in the North of England and is […]
The most ambitious European project for tackling bottlenecks in Alzheimer’s disease research and drug discovery PARIS — “The participation of ExonHit in this European initiative further validates our SpliceArray™ technology and our R&D expertise in Alzheimer’s disease” ExonHit Therapeutics S.A. (Paris:ALEHT) (Alternext: ALEHT) is pleased to announce that it has been chosen to participate in […]
HUNTINGTON BEACH, California and AMSTERDAM — Agendia, a world leader in molecular cancer diagnostics, announced today that it has received the Clinical Laboratory Permit from the New York State Department of Health. The New York State permit allows the company to receive commercial samples of MammaPrint, its FDA-cleared breast cancer recurrence test. With this latest […]
SAN DIEGO — Sequenom, Inc. (Nasdaq: SQNM), today announced an exclusive worldwide licensing agreement with Optherion, Inc. Under the agreement, Sequenom’s CAP accredited and CLIA-certified laboratory, Sequenom Center for Molecular Medicine (Sequenom CMM), obtained the rights to develop and commercialize diagnostic tests to predict genetic predisposition to late stage age-related macular degeneration (AMD). The license […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
